Recently, our federal agencies, under the prompting of the Trump administration, moved marijuana products regulated by a ...

On April 22, 2026, Acting Attorney General Todd Blanche issued a final order immediately placing both FDA-approved marijuana products ...

Anti-rescheduling provision advances in Congress; Lawmaker: “a lot” of colleagues smoke marijuana; LA medical cannabis in ...

The Justice Department reclassified marijuana as a Schedule III drug, a shift that affects research and taxes but not legalization ...

Members of Congress joined activists at a press conference on Wednesday to highlight the need for further federal marijuana ...

The move also essentially splits the cannabis market in states that have legalized weed for both medical and recreational consumers.

On April 22, 2026, the Acting U.S. Attorney General ordered two categories of marijuana moved from Schedule I to Schedule III of the Controlled Substances Act (CSA): FDA-approved drug products ...

(The Center Square) – Gov. Josh Shapiro thinks the Trump administration took an “important step” on Thursday after it redefined how the federal government classifies medical marijuana. Acting U.S.

Federal drug policy is undergoing a major shift. It could affect Mississippi medical marijuana. President Donald Trump recently signed an executive order changing the classification for medical ...

A cannabis industry group calls President Trump's reclassification of state-licensed medical marijuana as a less-dangerous drug "the most significant federal advancement in cannabis policy" in decades ...